FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Federal Register

DTC Study to Evaluate Adequate Provision for Non-Web Users

Federal Register notice: FDA seeks OMB approval for a new proposed information collection for a drug direct-to-consumer broadcast advertising study en...

Human Drugs

Revised Right-to-Try Bill Introduced in House

Lawmakers introduce a revised Right to Try bill in the House to improve access to experimental treatments for patients

New DTC Study Examining Adequate Provision for Non-Web Users

FDA announces new research to be conducted on direct-to-consumer (DTC) ads Utilization of Adequate Provision Among Low to Non-Internet Users.

Human Drugs

Transfer of a Premarket Notification Information Collection

Federal Register notice: FDA sends a proposed collection of information to OMB for review and clearance Transfer of a Premarket Notification.

Medical Devices

FDA Alert on Neurovascular Embolization Coil Imaging

FDA alerts healthcare providers to the potential for increased image artifact or image voids associated with magnetic resonance angiography imaging fo...

Human Drugs

FDA Dispute Resolution Action Seeks Another Hikma Study

FDA dispute resolution action reaffirms a 2017 complete response letter denying approval of a Hikma Pharmaceuticals ANDA for a generic version of Glax...

Medical Devices

FDA Clears DeGen Medical Modular Pedicle Screw

FDA clears a DeGen Medical 510(k) for the E3 MIS Modular Pedicle Screw System for thoraco-lumbar spine.

Medical Devices

Medtronic Gains Approval of Guardian Connect Glucose Monitor

FDA approves a Medtronic PMA for its Guardian Connect continuous glucose monitoring system for people with diabetes ages 14 to 75 years.

Medical Devices

Jury Awards $35 Million in Pelvic Mesh Case

A jury in Northern District of Indiana federal court returns a $35 million verdict in favor of plaintiffs Barbara and Anton Kaiser for alleged injurie...

FDA General

Since Our Last Issue ...

Industry news you may have missed since our last issue.